Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELTX
#3113
Elicio Therapeutics, Inc. - Common Stock
11.4
4
USD
+7.82%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+7.82%
Monthly Change
+10.11%
6 month change
+22.22%
Year Change
+14.40%
Previous Close
10.6
1
Open
11.4
4
Low
11.4
4
High
11.4
4
Volume
16
Markets
US Stock Market
Healthcare
ELTX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
29.96 M
30.11 M
10.24 M
15.95 M
18.4 M
19.09 M
Valuation ratios
Enterprise value
—
—
47.8 M
83.78 M
137.28 M
185.29 M
Price to earnings ratio
—
—
-0.85
-1.2
-3.09
-4.24
Price to sales ratio
—
—
32.8
404.13
—
14 K
Price to cash flow ratio
—
—
-0.92
-1.68
-3.3
-4.34
Price to book ratio
—
—
2.64
-5.5
74.5
26.96
Enterprise value to EBITDA ratio
—
—
-1.38
-1.89
-3.71
-4.99
Profitability ratios
Return on assets %
-0.57
-0.74
-1.3
-1.84
-1.53
-0.52
Return on equity %
-0.67
-0.89
-3.09
4.59
-24.19
8.23
Return on invested capital %
-1 821.24
-6 497.09
-1 922.03
-1 636.38
-1 994.92
-561.96
Gross margin %
98.47
100
100
100
—
100
Operating margin %
-138.84
-1 721.9
-5 077.41
-29.21 K
—
-81.55 K
EBITDA margin %
-131.86
-1 714.17
-4 923.15
-28.85 K
—
-80.58 K
Net margin %
-192.76
-1 686.53
-4 999.29
-33.7 K
—
-90.95 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.08
8.08
1.67
1.8
2.38
2.24
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.29
0.03
0.02
0.01
0
0
Solvency ratios
Debt to assets ratio
0
—
—
0.71
0.36
0.42
Debt to equity ratio
0
—
—
-1.77
5.75
-6.59
Long term debt to total assets ratio
0
—
—
0.71
0.39
—
Long term debt to total equity ratio
0
—
—
-1.77
6.11
—
Per share metrics
Operating cash flow per share
-1.86
-1.28
-6.47
-3.04
-2.41
-2.3
EBIT per share
-1.39
-1.32
-6.89
-3.67
-2.46
-2.27
EBITDA per share
-1.32
-1.31
-6.85
-3.64
-2.42
-2.24
Total debt per share
0
—
—
1.64
0.61
0.52
Cash per share
3.14
1.68
2.55
1.44
1.21
0.82
Net current asset value per share
3.23
1.71
3.23
1.7
1.26
0.89
Tangible book value per share
2.89
1.46
2.25
-0.93
0.11
-0.08
Working capital per share
2.83
1.5
1.3
0.75
0.73
0.49
Book value per share
2.89
1.46
2.25
-0.93
0.11
-0.08
News
Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
H.C. Wainwright raises Elicio Therapeutics price target to $17
Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
Elicio reports antigen spreading in 87% of evaluated cancer patients
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer
Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial
Elicio’s cancer therapy shows immune response across diverse HLA types
Elicio’s cancer vaccine ELI-002 shows strong immune response in 99% of patients
Elicio (ELTX) Q2 Loss Beats Estimates